MARKET

LEXXW

LEXXW

Lexaria Bioscien
NASDAQ
0.0223
0.0000
0.00%
Closed 12:06 12/17 EST
OPEN
0.0223
PREV CLOSE
0.0223
HIGH
0.0262
LOW
0.0223
VOLUME
9.56K
TURNOVER
--
52 WEEK HIGH
1.310
52 WEEK LOW
0.0180
MARKET CAP
--
P/E (TTM)
-0.0337
1D
5D
1M
3M
1Y
5Y
1D
Lexaria Bioscience Issues Warrants to Purchase 2.66 Million Shares
Reuters · 1d ago
Weekly Report: what happened at LEXXW last week (1208-1212)?
Weekly Report · 2d ago
Weekly Report: what happened at LEXXW last week (1201-1205)?
Weekly Report · 12/08 09:18
Weekly Report: what happened at LEXXW last week (1124-1128)?
Weekly Report · 12/01 09:17
Weekly Report: what happened at LEXXW last week (1117-1121)?
Weekly Report · 11/24 09:18
Weekly Report: what happened at LEXXW last week (1110-1114)?
Weekly Report · 11/17 09:18
Lexaria Extends Partnership With PharmaCO To April 2026 For Ongoing Evaluation Of DehydraTECH, Following Australian Study Data Review
Benzinga · 11/12 14:12
Lexaria Bioscience Extends Material Transfer Agreement with Pharmaceutical Company
Reuters · 11/12 14:10
More
About LEXXW
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

Webull offers Lexaria Bioscience Corp stock information, including NASDAQ: LEXXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LEXXW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LEXXW stock methods without spending real money on the virtual paper trading platform.